Home › Compare › FSGCY vs ABBV
FSGCY yields 4.63% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, FSGCY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FSGCY + ABBV for your $10,000?
First Gen Corporation, through its subsidiaries, engages in the power generation business in Philippines. It operates through FGPC, FGP, FNPC, Prime Meridian, EDC and Subsidiaries, and FG Hydro segments. The FGPC segment operates Santa Rita, a 1,000 MW combined cycle, natural gas-fired power plant. The FGP segment operates San Lorenzo, a 500 MW combined cycle, natural gas-fired power plant. The FNPC segment owns and operates San Gabriel plant, a 420 MW natural gas-fired power plant. The Prime Meridian segment owns and operates Avion plant, a 97 MW open-cycle natural gas-fired power plant. The EDC and Subsidiaries segment holds service contracts with the Department of Energy to explore, develop, and utilize the resources in the relevant 10 geothermal contract areas. This segment owns and operates 588.4 MW Unified Leyte geothermal power plants; 172.5 MW Palinpinon geothermal power plants; 140.0 MW Bac-Man geothermal power plants; 123.0 MW Tongonan geothermal power plant; 106.0 MW Mindanao geothermal power plants; 49.4 MW Nasulo geothermal power plant; 150 MW Burgos Wind Energy project; 6.82 MW Burgos Solar Energy project; and 5.17 MW Solar Rooftop projects. The FG Hydro segment operates Pantabangan-Masiway, a 132 MW Hydroelectric Plant. It sells its electricity to Manila Electric Company, National Power Corporation, electric cooperatives, privately-owned distribution utilities, large industrial clients, and National Grid Corporation of the Philippines. As of December 31, 2021, the company had an installed capacity of 3,495 megawatts (MW). First Gen Corporation was incorporated in 1998 and is based in Pasig, the Philippines. First Gen Corporation is a subsidiary of First Philippine Holdings Corporation.
Full FSGCY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.